Engineering of functional cartilage tissue using stem cells from synovial lining: a preliminary study

Clin Orthop Relat Res. 2008 Aug;466(8):1880-9. doi: 10.1007/s11999-008-0316-2. Epub 2008 May 30.

Abstract

Stem cells derived from synovial lining-synovial lining--derived stem cells or SDSCs--are a promising cell source for cartilage tissue engineering. We hypothesized that negatively selected SDSCs would form cartilage constructs and conventionally passaged SDSCs would be contaminated with macrophages, inhibiting SDSC-based chondrogenesis. We mixed SDSCs with fibrin gel and seeded the cells into polyglycolic acid scaffolds. After 3 days of incubation with a proliferative growth factor cocktail (containing transforming growth factor beta1 [TGF-beta1], insulin-like growth factor I [IGF-I], and basic fibroblast growth factor [FGF-2]), the cell-fibrin-polyglycolic acid constructs were transferred into rotating bioreactor systems and cultured with a chondrogenic growth factor cocktail (TGF-beta1/IGF-I) for up to 4 weeks. Tissue constructs based on negatively selected SDSCs had cartilaginous characteristics; were rich in glycosaminoglycans and collagen II; exhibited high expression of mRNA and protein for collagen II, aggrecan, and Sox 9; exhibited a negligible level of mRNA and protein for collagens I and X; and had an equilibrium modulus in the range of values measured for native human cartilage. Conventional passage yielded SDSCs with contaminating macrophages, which adversely affected the quality of tissue-engineered cartilage. We thus propose functional cartilage constructs could be engineered in vitro through the use of negatively isolated SDSCs.

MeSH terms

  • Animals
  • Chondrogenesis* / drug effects
  • Humans
  • Insulin-Like Growth Factor I
  • Macrophages
  • Polyglycolic Acid / chemistry
  • Stem Cell Transplantation
  • Swine
  • Synovial Membrane / cytology*
  • Tissue Engineering*
  • Tissue Scaffolds
  • Transforming Growth Factor beta / pharmacology

Substances

  • Transforming Growth Factor beta
  • Polyglycolic Acid
  • Insulin-Like Growth Factor I